FDA approves Nerivio for migraine treatment in children aged 8 years and older

The U.S. Food and Drug Administration has expanded the age indication for Theranica’s Nerivio, making it the first and only remote electrical neuromodulation (REN) wearable for migraine treatment for children aged 8 years and older.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup